<DOC>
	<DOCNO>NCT00722020</DOCNO>
	<brief_summary>To determine whether high frequency chest wall oscillation ( form VestTM ) superior regular asthma therapy management child hospitalize moderate severe asthma .</brief_summary>
	<brief_title>HFCWO Hospitalized Asthmatic Children</brief_title>
	<detailed_description>A historically control pilot study conduct pediatric patient 18 month 18 year age hospitalize diagnosis asthma reactive airway disease admit pediatric intensive care unit . Upon receive informed consent , patient treat HFCWO therapy via VEST . The primary endpoint time readiness discharge , lack need continue supportive care ( e.g. , intravenous fluid oxygen ) , bronchodilator treatment space least four hour apart .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Status Asthmaticus</mesh_term>
	<criteria>Any pediatric patient age 18 month 18 year admit Winthrop University Hospital 's pediatric floor intensive care unit diagnosis asthma reactive airway disease Patients chronic , comorbid respiratory condition ( e.g. , cerebral palsy , cystic fibrosis ) Those regularly use HFCWO Any patient exhibit absolute contraindication HFCWO therapy Absolute contraindication use HFCWO include head neck injury prior stabilization , active hemorrhage hemodynamic instability</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Bronchial Disease</keyword>
	<keyword>Status Asthmaticus</keyword>
	<keyword>High Frequency Chest Wall Oscillation</keyword>
	<keyword>Vest</keyword>
	<keyword>HFCWO</keyword>
</DOC>